A detailed history of Premier Path Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 6,079 shares of LLY stock, worth $5.5 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
6,079
Previous 6,124 0.73%
Holding current value
$5.5 Million
Previous $3.55 Billion 33.44%
% of portfolio
0.89%
Previous 0.78%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$592.2 - $792.28 $26,649 - $35,652
-45 Reduced 0.73%
6,079 $4.73 Billion
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $3.22 Million - $3.79 Million
6,124 New
6,124 $3.55 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Premier Path Wealth Partners, LLC Portfolio

Follow Premier Path Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Path Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Path Wealth Partners, LLC with notifications on news.